Published : Oct-2017
No. of Pages : 638
1 Table of Contents 2
1.1 List of Tables 12
1.2 List of Figures 24
2 Introduction 25
2.1 Breast Cancer Diagnostic Tests Overview 25
3 Products under Development 26
3.1 Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development 26
3.2 Breast Cancer Diagnostic Tests - Pipeline Products by Territory 27
3.3 Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 28
3.4 Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 29
3.5 Breast Cancer Diagnostic Tests - Ongoing Clinical Trials 30
4 Breast Cancer Diagnostic Tests - Pipeline Products under Development by Companies 31
4.1 Breast Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 31
4.2 Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development 38
5 Breast Cancer Diagnostic Tests Companies and Product Overview 44
5.1 2X Oncology Inc Company Overview 44
5.2 A&G Pharmaceutical Inc Company Overview 45
5.3 Abviva, Inc. Company Overview 47
5.4 Accelerated Medical Diagnostics Company Overview 48
5.5 Acobiom Company Overview 49
5.6 Affichem SA Company Overview 52
5.7 AIT Austrian Institute of Technology GmbH Company Overview 54
5.8 Albert Ludwigs University of Freiburg Company Overview 55
5.9 Alere Inc Company Overview 56
5.10 Almac Diagnostics Ltd Company Overview 57
5.11 Amarantus Bioscience Holdings Inc Company Overview 58
5.12 AngioGenex Inc Company Overview 59
5.13 ANGLE plc Company Overview 63
5.14 Anixa Diagnostics Corporation Company Overview 64
5.15 Armune BioScience Inc Company Overview 65
5.16 Arno Therapeutics Inc Company Overview 66
5.17 ArtemixRx Company Overview 68
5.18 Ascendant Diagnostics, LLC Company Overview 69
5.19 Assurance Biosciences, Inc. (Inactive) Company Overview 70
5.20 Atossa Genetics Inc Company Overview 71
5.21 Aurelium BioPharma Inc. Company Overview 75
5.22 Autoimmune Technologies LLC Company Overview 77
5.23 Avant Diagnostics, Inc. Company Overview 78
5.24 Ayanda Biosystems SA (Inactive) Company Overview 79
5.25 Baylor College of Medicine Company Overview 80
5.26 BCAL Diagnostics Pty Limited Company Overview 81
5.27 Becton Dickinson and Co Company Overview 82
5.28 Biocartis SA Company Overview 83
5.29 Biocrates Life Sciences AG Company Overview 85
5.30 Biodesix Inc Company Overview 86
5.31 BioGenex Laboratories Inc Company Overview 87
5.32 BioMarCare Technologies Ltd Company Overview 88
5.33 BioMark Diagnostics Inc. Company Overview 90
5.34 BioMarker Strategies LLC Company Overview 91
5.35 bioMerieux S.A. Company Overview 92
5.36 Biomoda, Inc. (Inactive) Company Overview 93
5.37 Bioprognos SL Company Overview 94
5.38 Biosceptre International Ltd Company Overview 95
5.39 BioSystems International Company Overview 96
5.40 BioTime Inc Company Overview 97
5.41 Caprion Biosciences Inc Company Overview 98
5.42 Celcuity LLC Company Overview 99
5.43 Cellanyx Diagnostics, Inc. Company Overview 101
5.44 CellMax Life Company Overview 102
5.45 CellXplore, Inc. Company Overview 103
5.46 Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Company Overview 104
5.47 Cepheid Company Overview 105
5.48 Ceres Nanosciences Inc Company Overview 108
5.49 Cernostics Inc. Company Overview 109
5.50 China Sky One Medical Inc Company Overview 110
5.51 Chronix Biomedical Inc Company Overview 111
5.52 Clarient Inc Company Overview 112
5.53 Cleveland Diagnostics Inc. Company Overview 113
5.54 CompanDX Ltd. Company Overview 114
5.55 Courtagen Life Sciences Inc Company Overview 115
5.56 Da An Gene Co Ltd Company Overview 116
5.57 Dana-Farber Cancer Institute Inc Company Overview 117
5.58 Dartmouth College Company Overview 118
5.59 Diaxonhit SA Company Overview 119
5.60 Dublin City University Company Overview 122
5.61 Eventus Diagnostics Inc (Inactive) Company Overview 123
5.62 Exosomics Siena SpA Company Overview 127
5.63 Fahy Gurteen UK Ltd Company Overview 128
5.64 Fina Biotech SL Company Overview 129
5.65 Fluxion Biosciences Inc Company Overview 130
5.66 Fournira Optime Diagnostics Company Overview 131
5.67 French National Institute of Health and Medical Research Company Overview 132
5.68 Genome Diagnostics Pvt. Ltd. Company Overview 134
5.69 Genomic Health Inc Company Overview 135
5.70 GenomicTree Inc Company Overview 136
5.71 Genoptix Inc Company Overview 137
5.72 George Washington University Company Overview 139
5.73 German Cancer Research Center Company Overview 140
5.74 Ghent University Company Overview 142
5.75 GlycoZym Company Overview 143
5.76 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 144
5.77 Hai Kang Life Corp Ltd Company Overview 145
5.78 Health Discovery Corp Company Overview 146
5.79 Hebrew University of Jerusalem Company Overview 147
5.80 Heragen Inc Company Overview 148
5.81 Hummingbird Diagnostics GmbH Company Overview 149
5.82 Ikonisys Inc Company Overview 150
5.83 Imagion Biosystems Inc Company Overview 151
5.84 Immunovia AB Company Overview 152
5.85 Insight Genetics Inc Company Overview 153
5.86 Institute of Cancer Research Company Overview 154
5.87 IRIS International Inc Company Overview 155
5.88 IV Diagnostics Inc Company Overview 156
5.89 John Hopkins University Company Overview 157
5.90 Jonakee Cancer Research, Inc. Company Overview 159
5.91 Kailos Genetics, Inc. Company Overview 160
5.92 Kalgene Pharmaceuticals Inc Company Overview 161
5.93 King Abdullah University of Science and Technology Company Overview 162
5.94 Leica Biosystems GmbH Company Overview 163
5.95 Louisville Bioscience, Inc. Company Overview 164
5.96 MabCure Inc. Company Overview 165
5.97 Matrix-Bio, Inc. Company Overview 166
5.98 MDNA Life Sciences Inc Company Overview 169
5.99 MDxHealth SA Company Overview 170
5.100 Medical Prognosis Institute A/S Company Overview 171
5.101 MEDITE Cancer Diagnostics Inc Company Overview 173
5.102 MedMira Inc. Company Overview 174
5.103 Metabolomic Technologies Inc Company Overview 175
5.104 MetaStat Inc Company Overview 176
5.105 Milagen Inc Company Overview 177
5.106 Molecular Warehouse Ltd Company Overview 178
5.107 Morphotek Inc Company Overview 179
5.108 Myriad Genetics Inc Company Overview 180
5.109 NanoString Technologies Inc Company Overview 185
5.110 National University of Ireland Galway Company Overview 186
5.111 New York University Company Overview 187
5.112 Newcastle University Company Overview 188
5.113 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 189
5.114 Nuclea Biotechnologies Inc. (Inactive) Company Overview 191
5.115 Nuvera Biosciences Inc Company Overview 194
5.116 Olink Proteomics AB Company Overview 197
5.117 Olympia Diagnostics, Inc Company Overview 200
5.118 Oncimmune (USA) LLC Company Overview 201
5.119 OncoCyte Corp Company Overview 202
5.120 Onconome, Inc. (Inactive) Company Overview 204
5.121 OncoStem Diagnostics Pvt. Ltd Company Overview 206
5.122 OncoVista Innovative Therapies Inc Company Overview 207
5.123 On-Q-ity, Inc. (Inactive) Company Overview 208
5.124 Orion Genomics LLC Company Overview 209
5.125 OTraces Inc. Company Overview 210
5.126 Oxford Impedance Diagnostics Ltd Company Overview 211
5.127 PeriRx LLC Company Overview 212
5.128 Power3 Medical Products, Inc. Company Overview 213
5.129 Precision Biologics Inc Company Overview 214
5.130 PreMD Inc (Inactive) Company Overview 215
5.131 Princeton University Company Overview 216
5.132 Proplex Technologies Llc Company Overview 217
5.133 Protagen AG Company Overview 218
5.134 Proteome Sciences Plc Company Overview 219
5.135 Proteomika Company Overview 220
5.136 Provista Diagnostics Inc Company Overview 221
5.137 Purdue University Company Overview 222
5.138 Qiagen NV Company Overview 223
5.139 Quest Diagnostics Inc Company Overview 224
5.140 Rna Diagnostics Inc. Company Overview 225
5.141 Roche Diagnostics International Ltd Company Overview 228
5.142 Rosetta Genomics Ltd Company Overview 232
5.143 Royal College of Surgeons in Ireland Company Overview 233
5.144 RWTH Aachen University Company Overview 234
5.145 Savicell Diagnostic Ltd. Company Overview 235
5.146 Selventa Inc Company Overview 236
5.147 Sengenics International Pte Ltd Company Overview 237
5.148 Siamab Therapeutics Inc Company Overview 238
5.149 Siemens Healthcare GmbH Company Overview 239
5.150 Soricimed Biopharma Inc Company Overview 240
5.151 Target Discovery Inc (Inactive) Company Overview 242
5.152 Taxor Diagnostics, LLC Company Overview 243
5.153 TechnoGenesys, Inc. Company Overview 244
5.154 Treos Bio Inc Company Overview 245
5.155 Trinity College Dublin Company Overview 246
5.156 Universal Diagnostics SL Company Overview 247
5.157 University of Alberta Company Overview 248
5.158 University of Bergen Company Overview 249
5.159 University of Bonn Company Overview 250
5.160 University of California Riverside Company Overview 252
5.161 University of California San Diego Company Overview 253
5.162 University of Chicago Company Overview 254
5.163 University of Colorado Company Overview 255
5.164 University of Iowa Company Overview 257
5.165 University of Kansas Company Overview 259
5.166 University of Lyon Company Overview 260
5.167 University of Maryland Baltimore Company Overview 261
5.168 University of Missouri Company Overview 262
5.169 University of Nebraska Company Overview 263
5.170 University of Oxford Company Overview 264
5.171 University of Pittsburgh Company Overview 265
5.172 University of South Florida Company Overview 266
5.173 University of Texas MD Anderson Cancer Center Company Overview 267
5.174 University of Wisconsin Madison Company Overview 268
5.175 US Biomarkers Inc Company Overview 269
5.176 Vermillion Inc Company Overview 270
5.177 Viomics Inc. Company Overview 272
5.178 Vitatex Inc. Company Overview 273
5.179 Vitruvian Biomedical Inc Company Overview 274
5.180 VolitionRX Ltd Company Overview 275
5.181 XEPTAGEN SpA Company Overview 277
5.182 Xiamen Zeesan Biotech Co.,Ltd Company Overview 279
5.183 Zetiq Technologies Ltd Company Overview 280
6 Breast Cancer Diagnostic Tests - Recent Developments 281
6.1 Sep 14, 2017: Industry Leaders Allergan and Sientra Invest in The American Society for Aesthetic Plastic Surgery for Breast Implant Research 281
6.2 Sep 12, 2017: Cernostics Announces Leadership Team Expansion 281
6.3 Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion 282
6.4 Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses 283
6.5 Sep 04, 2017: Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018. 283
6.6 Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results 284
6.7 Aug 30, 2017: bioMerieux - First-Half 2017 Results 286
6.8 Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy 290
6.9 Aug 29, 2017: Todos Medical Appoints Dr. Meir Silver as Vice President of Clinical Research and Regulatory Affairs 290
6.10 Aug 24, 2017: Novartis appoints Bertrand Bodson as Chief Digital Officer 290
6.11 Aug 24, 2017: Astellas Announces Personnel Changes and Organizational Changes 291
6.12 Aug 24, 2017: AroCell: Interim report, Q2 2017 292
6.13 Aug 24, 2017: Sectra Signs Breast Imaging PACS Contract With UC San Diego Health 293
6.14 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers 294
6.15 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson 294
6.16 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 295
6.17 Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results 296
6.18 Aug 14, 2017: Atossa Genetics Announces Second Quarter 2017 Financial Results And Provides Company Update 298
6.19 Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 298
6.20 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update 301
6.21 Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results 302
6.22 Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion 303
6.23 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 303
6.24 Aug 02, 2017: Clovis Oncology Announces Second Quarter 2017 Operating Results 305
6.25 Aug 01, 2017: Successful DRP prediction of patients treated with 2X-121, the PARP inhibitor recently licensed from Eisai 308
6.26 Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results 309
6.27 Aug 01, 2017: Proteome Sciences: Directorate changes 313
6.28 Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress 314
6.29 Aug 01, 2017: Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights 315
7 Appendix 631
7.1 Methodology 631
7.2 About GlobalData 634
7.3 Contact Us 634
7.4 Disclaimer 634
1.1 List of Tables
Table 1: Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development 30
Table 2: Breast Cancer Diagnostic Tests - Pipeline Products by Territory 31
Table 3: Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 32
Table 4: Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 33
Table 5: Breast Cancer Diagnostic Tests - Ongoing Clinical Trials 34
Table 6: Breast Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 35
Table 7: Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development 42
Table 8: 2X Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 9: 2X-121 Companion Diagnostic Assay - Product Status 48
Table 10: 2X-121 Companion Diagnostic Assay - Product Description 48
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 12: Onco 88 - Breast Cancer - Product Status 49
Table 13: Onco 88 - Breast Cancer - Product Description 49
Table 14: OncoStain 88 - Breast Cancer - Product Status 50
Table 15: OncoStain 88 - Breast Cancer - Product Description 50
Table 16: Abviva, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
Table 17: Diagnostic Assay - Mammastatin - Product Status 51
Table 18: Diagnostic Assay - Mammastatin - Product Description 51
Table 19: Accelerated Medical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 52
Table 20: Companion Diagnostic Test - Oxaliplatin - Product Status 52
Table 21: Companion Diagnostic Test - Oxaliplatin - Product Description 52
Table 22: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 53
Table 23: Companion Diagnostic Test - Breast Cancer - Product Status 53
Table 24: Companion Diagnostic Test - Breast Cancer - Product Description 53
Table 25: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status 54
Table 26: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description 54
Table 27: Diagnostic/Prognostic Assay - Breast Cancer - Product Status 54
Table 28: Diagnostic/Prognostic Assay - Breast Cancer - Product Description 55
Table 29: Affichem SA Pipeline Products & Ongoing Clinical Trials Overview 56
Table 30: AF300 Based Chromatographic Kit - Product Status 56
Table 31: AF300 Based Chromatographic Kit - Product Description 56
Table 32: AF300 Based Enzymatic Immunoassay Kit - Product Status 57
Table 33: AF300 Based Enzymatic Immunoassay Kit - Product Description 57
Table 34: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 58
Table 35: Diagnostic Assay - Breast Cancer - Product Status 58
Table 36: Diagnostic Assay - Breast Cancer - Product Description 58
Table 37: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 59
Table 38: mRNA Based Diagnostic Assay - Breast Cancer - Product Status 59
Table 39: mRNA Based Diagnostic Assay - Breast Cancer - Product Description 59
Table 40: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 41: NMP66 Test - Product Status 60
Table 42: NMP66 Test - Product Description 60
Table 43: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
Table 44: DNA Damage Response Deficiency Assay - Breast Cancer - Product Status 61
Table 45: DNA Damage Response Deficiency Assay - Breast Cancer - Product Description 61
Table 46: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 47: NuroPro - Breast Cancer - Product Status 62
Table 48: NuroPro - Breast Cancer - Product Description 62
Table 49: AngioGenex Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 50: Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Status 63
Table 51: Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Description 64
Table 52: Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Status 64
Table 53: Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Description 64
Table 54: Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Status 65
Table 55: Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Description 65
Table 56: Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Status 65
Table 57: Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Description 66
Table 58: Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Status 66
Table 59: Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Description 66
Table 60: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 67
Table 61: Parsortix-Based Test - Breast Cancer - Product Status 67
Table 62: Parsortix-Based Test - Breast Cancer - Product Description 67
Table 63: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 68
Table 64: Biomarker Test - Breast Cancer - Product Status 68
Table 65: Biomarker Test - Breast Cancer - Product Description 68
Table 66: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 67: Diagnostic Test - Breast Cancer - Product Status 69
Table 68: Diagnostic Test - Breast Cancer - Product Description 69
Table 69: Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 70: Activated Estrogen Receptor Biomarker Assay - Product Status 70
Table 71: Activated Estrogen Receptor Biomarker Assay - Product Description 70
Table 72: Onapristone Companion Diagnostic Assay - Breast Cancer - Product Status 71
Table 73: Onapristone Companion Diagnostic Assay - Breast Cancer - Product Description 71
Table 74: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 72
Table 75: ArtemixRx Prognostic Test - Breast Cancer - Product Status 72
Table 76: ArtemixRx Prognostic Test - Breast Cancer - Product Description 72
Table 77: Ascendant Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 73
Table 78: MelodyDX - Product Status 73
Table 79: MelodyDX - Product Description 73
Table 80: Assurance Biosciences, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74
Table 81: Salivary-Based Assay - Breast Cancer - Product Status 74
Table 82: Salivary-Based Assay - Breast Cancer - Product Description 74
Table 83: Atossa Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 75
Table 84: ArgusCYTE Breast Health Test - Product Status 75
Table 85: ArgusCYTE Breast Health Test - Product Description 75
Table 86: Companion Diagnostic Test - Breast Cancer - Product Status 76
Table 87: Companion Diagnostic Test - Breast Cancer - Product Description 76
Table 88: Companion Diagnostic Test - PED - Product Status 76
Table 89: Companion Diagnostic Test - PED - Product Description 77
Table 90: Next Generation MASCT System - Product Status 77
Table 91: Next Generation MASCT System - Product Description 77
Table 92: NextCYTE Breast Cancer Test - Product Status 78
Table 93: NextCYTE Breast Cancer Test - Product Description 78
Table 94: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
Table 95: Breast Cancer Screening Test - Product Status 79
Table 96: Breast Cancer Screening Test - Product Description 79
Table 97: MMD ELISA Test - Breast Cancer - Product Status 80
Table 98: MMD ELISA Test - Breast Cancer - Product Description 80
Table 99: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 81
Table 100: Diagnostic Assay - Breast Cancer - Product Status 81
Table 101: Diagnostic Assay - Breast Cancer - Product Description 81
Table 102: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 103: Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Status 82
Table 104: Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Description 82
Table 105: Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83
Table 106: Diagnostic Test - Breast Cancer - Product Status 83
Table 107: Diagnostic Test - Breast Cancer - Product Description 83
Table 108: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 84
Table 109: Mitochondria-Regulated Cancer Signature - Breast Cancer - Product Status 84
Table 110: Mitochondria-Regulated Cancer Signature - Breast Cancer - Product Description 84
Table 111: BCAL Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 85
Table 112: BCAL Test - Breast Cancer - Product Status 85
Table 113: BCAL Test - Breast Cancer - Product Description 85
Table 114: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 86
Table 115: Diagnostic Test - Breast Cancer - Product Status 86
Table 116: Diagnostic Test - Breast Cancer - Product Description 86
Table 117: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 87
Table 118: Idylla Liquid Biopsy Test - Breast Cancer - Product Status 87
Table 119: Idylla Liquid Biopsy Test - Breast Cancer - Product Description 87
Table 120: Idylla Solid Biopsy Test - Breast Cancer - Product Status 88
Table 121: Idylla Solid Biopsy Test - Breast Cancer - Product Description 88
Table 122: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview 89
Table 123: Metabolomic Biomarker Assay - Breast Cancer - Product Status 89
Table 124: Metabolomic Biomarker Assay - Breast Cancer - Product Description 89
Table 125: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 90
Table 126: VeriStrat - Breast Cancer - Product Status 90
Table 127: VeriStrat - Breast Cancer - Product Description 90
Table 128: BioGenex Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 91
Table 129: IHC System - Breast Cancer - Product Status 91
Table 130: IHC System - Breast Cancer - Product Description 91
Table 131: BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 92
Table 132: Breast PARpanel Biopsy - Product Status 92
Table 133: Breast PARpanel Biopsy - Product Description 92
Table 134: Breast PARpanel Blood - Product Status 93
Table 135: Breast PARpanel Blood - Product Description 93
Table 136: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
Table 137: Metabolomics-based Diagnostic Assay - Breast Cancer - Product Status 94
Table 138: Metabolomics-based Diagnostic Assay - Breast Cancer - Product Description 94
Table 139: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 95
Table 140: Ex Vivo Biomarker Test - Breast Cancer - Product Status 95
Table 141: Ex Vivo Biomarker Test - Breast Cancer - Product Description 95
Table 142: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 96
Table 143: Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status 96
Table 144: Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description 96
Table 145: Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97
Table 146: CyPath Diagnostic Assay - Breast Cancer - Product Status 97
Table 147: CyPath Diagnostic Assay - Breast Cancer - Product Description 97
Table 148: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview 98
Table 149: MBDAA Breast Cancer Test - Product Status 98
Table 150: MBDAA Breast Cancer Test - Product Description 98
Table 151: Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
Table 152: Breast Cancer IHC Diagnostic Test - Product Status 99
Table 153: Breast Cancer IHC Diagnostic Test - Product Description 99
Table 154: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 100
Table 155: Diagnostic Test - Breast Cancer - Product Status 100
Table 156: Diagnostic Test - Breast Cancer - Product Description 100
Table 157: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 101
Table 158: Confirmatory Diagnostic Blood Test - Breast Cancer - Product Status 101
Table 159: Confirmatory Diagnostic Blood Test - Breast Cancer - Product Description 101
Table 160: Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 102
Table 161: Diagnostic Assay - Breast Cancer - Product Status 102
Table 162: Diagnostic Assay - Breast Cancer - Product Description 102
Table 163: Celcuity LLC Pipeline Products & Ongoing Clinical Trials Overview 103
Table 164: CELx HSF Test - Product Status 103
Table 165: CELx HSF Test - Product Description 103
Table 166: CELx Test - Breast Cancer - Product Status 104
Table 167: CELx Test - Breast Cancer - Product Description 104
Table 168: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
1.2 List of Figures
Figure 1: Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development 30
Figure 2: Breast Cancer Diagnostic Tests - Pipeline Products by Territory 31
Figure 3: Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 32
Figure 4: Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 33
Figure 5: Breast Cancer Diagnostic Tests - Ongoing Clinical Trials 34
